Latest News

Journal Articles

Brain and neurologic

Combination immunotherapy shows promising preclinical results in glioblastoma

Genetic biomarkers of drug response for small-molecule therapeutics targeting the RTK/Ras/PI3K, p53 or Rb pathway in glioblastoma

Novel small molecule inhibitors of the OLIG2 transcription factor: promising new therapeutics for glioblastoma

Breast

No association found between psychological stress and breast cancer incidence

Chemotherapy-induced cardiotoxicity in breast cancer patients

Rationalizing the use of functionalized poly-lactic-co-glycolic acid nanoparticles for dendritic cell-based targeted anticancer therapy

Colorectal

Metastatic colorectal cancer: markers to inform treatment selection

Statins may be associated with reduced mortality in common cancers

Tumor location: prognostic or predictive marker in metastatic colorectal cancer?

Endocrine

Targeting PI3K isoform shows therapeutic promise in pancreatic neuroendocrine tumors

New treatment hopes for patients with inoperable neuroendocrine cancers?

Risk-stratified follow-up of patients with medullary thyroid carcinoma

Gastrointestinal

Safety and efficacy of regorafenib determined in Phase III liver cancer trial

Current advances in targeted therapies for metastatic gastric cancer: improving patient care

Tumors may resist treatment by ‘stealing’ blood vessels

Genitourinary

Systemic therapy for metastatic bladder cancer in 2016 and beyond

New research could help personalize treatment in early bladder cancer

FGFR3 and Cyclin D3 as urine biomarkers of bladder cancer recurrence

Gynecologic

Should older women be vaccinated against human papillomavirus, too?

BRCA1 gene may increase serous endometrial cancer risk

Ovarian clear cell carcinoma could be targeted with leukemia drug

Head and neck

Novel targets for natural killer/T-cell lymphoma immunotherapy

Professor Jan Vermorken discusses the impact of new data on the standard-of-care treatment for recurrent/metastatic head and neck cancer

Dr Lisa Licitra discusses the current and future treatment landscape in recurrent/metastatic head and neck cancer

Hematologic

Novel discovery improves profiling of acute myeloid leukemia patients for targeted therapies

Targeting B-cell receptor signaling in leukemia and lymphoma: how and why?

Uncovering the genetic mechanism driving acute myeloid leukemia

Lung

Statins may be associated with reduced mortality in common cancers

DNA repair in lung cancer: potential not yet reached

Neurotrophic tyrosine kinase gene fusions: another opportunity for targeting in lung cancer

Pancreatic

Developments in miRNA gene signaling pathways in pancreatic cancer

Pancreatic cancer – novel screening technique identifies key gene

Targeting PI3K isoform shows therapeutic promise in pancreatic neuroendocrine tumors

Prostate

Could anti-PD-1 antibody be used as treatment for metastatic prostate cancer?

Statins may be associated with reduced mortality in common cancers

Differences in metabolic pathways in castration resistant prostate cancer and androgen-dependent prostate cancer may lead to new therapies

Rare tumors

Low-dose brachytherapy strategies to treat uveal melanoma: is less more?

Should clinical trials be approached differently for rare cancers?

Novel targets for natural killer/T-cell lymphoma immunotherapy

Skin

Predictors of tumor-infiltrating lymphocyte efficacy in melanoma

Advanced melanoma patient in remission 5 years after combination immunotherapies

The role of radiation therapy in the management of cutaneous melanoma